Log ind
POLFOTO_46554036.jpg
Foto: Philip Davali/POLFOTO/arkiv

Bavarian Nordic signs new commercial agreement

Top picks in English:

The Danish biotech company enters into a partnership with French counterpart which ensures Bavarian Nordic the rights to develop and commercialize new poxvirus-based vaccines.


BY SØREN DURAN DUUS
Offentliggjort 19.04.17 kl. 14:32

Log ind for at læse artikler

Velkommen til MedWatch. En del af vores indhold er eksklusivt og forbeholdt vores brugere.

Prøv os gratis i 14 dage

Få fuld adgang til vores kvalitetsjournalistik med et gratis prøveabonnement.

Sign up for MedWatch newsletter
Mest læste Top picks in English

Genmab accelerates research efforts

JanVanDerWinkel02.jpg Top picks in English:

Genmab will need to identify its next winning ticket in the coming three to four years, and its CEO is fully convinced that the drug is already hiding in the biotech company’s pipeline. The firm is now increasing its R&D budget in a bid to identify the winner.

Here is what Danish drug companies pay their workers

Top picks in English:

The average monthly salary in the private pharmaceutical industry in Denmark is DKK 57,109. Make the jump to find out which company pays the highest wages and learn how much the rest of the industry pays as well.

Genmab CEO: “Janssen is a military machine”

Top picks in English:

Janssen is pushing hard for new approvals for the Genmab-developed cancer drug Darzalex which is being tested in a range of phase III studies. This year, the biotech expects data from a trial that could clear the product for front-line use against multiple myeloma and double the potential market, says its CEO.

Novo among the 100 most valuable companies in the world

Top picks in English:

Novo Nordisk has made it onto the list of the world’s 100 most valuable companies for the first time, but the Danish company is still trailing the biggest players in the pharmaceutical industry.

Staff chief to leave Novo Nordisk

Top picks in English:

Novo Nordisk has announced changes to its management structure, which sees the executive management team cut from seven to six people, as EVP and Chief of Staff Lise Kingo has chosen to resign.

Boehringer appoints new chief of Danish unit

Top picks in English:

German drug group Boehringer Ingelheim has replaced its executive in charge of the business unit in Denmark, with a young doctor from within the ranks taking the reins.

Forsiden lige nu

Ammoniakudslip fra medico-selskab sender syv på sygehus

Skadestue Lægevagten skilt hospital.jpg Medico & Rehab:

Syv personer er bragt til sygehuse efter et udslip af ammoniak i Nordsjælland. Folk i området skal blive inde.

MW-indeks: Investordarling vender kursen med flotte salgstal

Medicinal & Biotek:

En investordarling, som ellers har været prøvet på aktiekursen i de seneste uger, har med flotte nye salgstal vendt skuden, mens andre gode nyheder ikke finder nåde for investorernes blik.

Laboratorieleverandør vokser på nordisk salg

Medico & Rehab:

Den danske laboratorieleverandør Ramcon glæder sig over fremgang i både bruttofortjeneste og årsresultat. Især har væksten været markant i Norden uden for Danmark.

Valeant sætter pris på ”Løvens" psoriasissatsning

Medicinal & Biotek:

Det canadiske medicinalselskab Valeant har offentliggjort den amerikanske pris på psoriasismidlet brodalumab, som danske Leo Pharma har de europæiske enerettigheder til.

GSK dømt til at betale i selvmordssag

Medicinal & Biotek:

Selvom der var tale om en generisk version af et lægemiddel, som var årsagen til et dødsfald, er det alligevel GlaxoSmithKline, der som originalproducenten af det oprindelige lægemiddel, skal betale i sagen.

Medicoindustrien mangler folk med styr på juraen

Medico & Rehab:

Mens medicobranchen fortsat skriger på flere ingeniører, er der også et andet medarbejderbehov, som er begyndt at blive mere og mere dominant, nemlig folk, der kan tage sig af de regulatoriske affærer i de enkelte virksomheder. De er nemlig en mangelvare.

ANNONCE
ANNONCE


ANNONCE